Clinical OMICs - Issue 5 - (Page 4)

Clinically Actionable Genomics: From Sequencing to Personalized Medicine 9 Speakers Webinar Free Registration! Click here to register Richard Mazzarella, Ph.D. Chief Science Officer Appistry Weiyi Chen, Ph.D. Molecular Diagnostics Director Cancer Genetics MODERATOR Genome sequencing, massive amounts of genetic data, bioinformatics, and associated analytics are rapidly redefining clinical practice, particularly in oncology. All this represents a major and significant step forward in the evolution of personalized medicine. This webinar will focus on describing those technologies and strategies that are transforming genomic data into clinically actionable intelligence. Specific examples of how such data has enabled the validation of therapies for one type of cancer will be illustrated. In addition, it will also be shown how these same validated therapies can be used to treat another form of the disease. Also under discussion will be the current and future role of novel molecular diagnostics in clinical oncology. www.clinicalomics.com Publisher & CEO Editor In Chief Mary Ann Liebert John Sterling Group Publisher Sande Giaccone (sgiaccone@clinicalomics.com) Managing Editor Tamlyn L. Oliver (toliver@clinicalomics.com) Production Editor Senior Editor Technical Editor Online Editor Senior News Editor Robert M. Reis Kevin Mayer Patricia F. Dimond, Ph.D. Patrice Bartell Alex Philippidis Assistant Editor Sunya Bhutta Art Director James Lambo Director, Digital Media Bill Levine Audience Development Kwafo Anoff Online Product Manager Thomas Mathew Web Producer Melinda Kucsera Sales Administrator Michelle Stolowicki Office Assistant Elizabeth Ramirez Design & Layout Nora Wertz Advertising Material Wanda Sanchez wsanchez@liebertpub.com The views, opinions, findings, conclusions, and recommendations set forth in any article in Clinical Omics are solely those of the authors of those articles and do not necessarily reflect the views, policy, or position of Clinical Omics, its Publisher, or its editorial staff and should not be attributed to any of them. All advertisements are subject to review by the Publisher. The acceptance of advertisements does not constitute an endorsement of the product or service advertised. WHO SHOULD ATTEND * Pathologists * Oncologists * Cancer drug developers * Clinical laboratory scientists John Sterling Editor in Chief Clinical OMICs View it Now! On Demand Sponsored by Clinical Omics (ISSN-2334-1351) is published online semimonthly by Mary Ann Liebert, Inc., 140 Huguenot Street, 3rd Floor, New Rochelle, NY 10801-5215. For subscription information go to: www.clinicalomics.com Copyright © 2014 by Mary Ann Liebert, Inc., New Rochelle, NY. http://www.clinicalomics.com https://www.dxma.org/clinically-actionable-genomics http://www.clinicalomics.com

Table of Contents for the Digital Edition of Clinical OMICs - Issue 5

Contents

Clinical OMICs - Issue 5